tiprankstipranks
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Holding ELVN?
Track your performance easily

Enliven Therapeutics (ELVN) Similar Stocks

286 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Enliven Therapeutics
$23.86
$1.18B
91.06%
5 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$33.00
$4.10B
-54.46%
12 Buy
7 Hold
0 Sell
Moderate Buy
Immunovant
$23.63
$3.47B
-45.40%
7 Buy
1 Hold
0 Sell
Strong Buy
Seres Therapeutics
$0.85
$145.13M
-29.75%
2 Buy
0 Hold
1 Sell
Moderate Buy
Fulcrum Therapeutics
$4.48
$241.65M
-40.27%
1 Buy
3 Hold
0 Sell
Hold
Ocugen
$0.83
$242.06M
43.10%
3 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$4.30
$960.06M
-40.11%
5 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ELVN
Enliven Therapeutics
24.15
10.49
76.79%
APLS
Apellis Pharmaceuticals
33.00
-39.47
-54.46%
IMVT
Immunovant
23.63
-20.16
-46.04%
MCRB
Seres Therapeutics
0.85
-0.58
-40.56%
FULC
Fulcrum Therapeutics
4.48
-3.30
-42.42%
OCGN
Ocugen
0.83
0.18
27.69%
SANA
Sana Biotechnology
4.30
-0.86
-16.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis